HIV-1 integrase inhibitor
CAS: 544467-07-4
Ref. 3D-FA64909
25mg | 72,00 € | ||
50mg | 112,00 € | ||
100mg | 172,00 € | ||
250mg | 311,00 € | ||
500mg | 470,00 € |
Informação sobre produto
- 4-[3-(Azidomethyl)phenyl]-2-hydroxy-4-oxo-2-butenoic acid
Integrase inhibitors are a class of drugs that inhibit the function of integrase. They prevent HIV-1 from integrating into the host cell genome and thus arrest the progression of HIV-1 infection. There are many analytical methods that can be used to determine the presence of integrase in cells, such as transfection experiments, toxicity studies, drug interactions, and bioassays. One pharmacological agent that has been shown to inhibit integrase is raltegravir (Isentress), which is a protease inhibitor. Raltegravir is available in tablet form for oral administration. It inhibits HIV-1 replication by binding to the active site of human immunodeficiency virus type 1 (HIV-1) integrase and prevents its integration into host cell DNA. This drug has been shown to be beneficial when used in conjunction with other antiretroviral agents for treating HIV-1 infections.
Propriedades químicas
Consulta técnica sobre: 3D-FA64909 HIV-1 integrase inhibitor
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.